期刊文献+

Development of a prognostic scoring system for resectable hepatocellular carcinoma 被引量:1

Development of a prognostic scoring system for resectable hepatocellular carcinoma
下载PDF
导出
摘要 AIM To develop a prognostic scoring system for overall survival(OS) of patients undergoing liver resection(LR) for hepatocellular carcinoma(HCC).METHODS Consecutive patients who underwent curative LR for HCC between 2000 and 2013 were identified. The series was randomly divided into a training and a validation set. A multivariable Cox model for OS was fitted to the training set. The beta coefficients derived from the Cox model were used to define a prognostic scoring system for OS. The survival stratification was then tested, and the prognostic scoring system was compared with the European Association for the Study of the Liver(EASL)/American Association for the Study of Liver Diseases(AASLD) surgical criteria by means of Harrell's C statistics.RESULTS A total of 917 patients were considered. Five variables independently correlated with post-LR survival: Model for End-stage Liver Disease score, hepatitis C virus infection, number of nodules, largest diameter and vascular invasion. Three risk classes were identified, and OS for the three risk classes was significantly different both in the training(P < 0.0001) and the validation set(P = 0.0002). Overall, 69.4% of patients were in the low-risk class, whereas only 37.8% were eligible to surgery according to EASL/AASLD. Survival of patients in the low-risk class was not significantly different compared with surgical indication for EASL/AASLD guidelines(77.2 mo vs 82.5 mo respectively, P = 0.22). Comparison of Harrell's C statistics revealed no significant difference in predictive power between the two systems(-0.00999, P = 0.667).CONCLUSION This study established a new prognostic scoring system that may stratify HCC patients suitable for surgery, expanding surgical eligibility with respect to EASL/AASLD criteria with no harm on survival. AIM To develop a prognostic scoring system for overall survival(OS) of patients undergoing liver resection(LR) for hepatocellular carcinoma(HCC).METHODS Consecutive patients who underwent curative LR for HCC between 2000 and 2013 were identified. The series was randomly divided into a training and a validation set. A multivariable Cox model for OS was fitted to the training set. The beta coefficients derived from the Cox model were used to define a prognostic scoring system for OS. The survival stratification was then tested, and the prognostic scoring system was compared with the European Association for the Study of the Liver(EASL)/American Association for the Study of Liver Diseases(AASLD) surgical criteria by means of Harrell’s C statistics.RESULTS A total of 917 patients were considered. Five variables independently correlated with post-LR survival: Model for End-stage Liver Disease score, hepatitis C virus infection, number of nodules, largest diameter and vascular invasion. Three risk classes were identified, and OS for the three risk classes was significantly different both in the training(P < 0.0001) and the validation set(P = 0.0002). Overall, 69.4% of patients were in the low-risk class, whereas only 37.8% were eligible to surgery according to EASL/AASLD. Survival of patients in the low-risk class was not significantly different compared with surgical indication for EASL/AASLD guidelines(77.2 mo vs 82.5 mo respectively, P = 0.22). Comparison of Harrell’s C statistics revealed no significant difference in predictive power between the two systems(-0.00999, P = 0.667).CONCLUSION This study established a new prognostic scoring system that may stratify HCC patients suitable for surgery, expanding surgical eligibility with respect to EASL/AASLD criteria with no harm on survival.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第36期8194-8202,共9页 世界胃肠病学杂志(英文版)
关键词 HEPATOCELLULAR carcinoma LIVER RESECTION LIVER CIRRHOSIS Prognosis SURVIVAL study Hepatocellular carcinoma Liver resection Liver cirrhosis Prognosis Survival study
  • 相关文献

参考文献23

  • 1Henri Bismuth.??Surgical anatomy and anatomical surgery of the liver(J)World Journal of Surgery . 1982 (1) 被引量:1
  • 2Sposito C,Battiston C,Facciorusso A,et al.Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma. British Journal of Surgery . 2016 被引量:1
  • 3Sullivan Lisa M,Massaro Joseph M,D’Agostino Ralph B.Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Statistics in Medicine . 2004 被引量:1
  • 4Vitale A,Burra P,Frigo AC,Trevisani F,Farinati F,Spolverato G,Volk M,Giannini EG,Ciccarese F,Piscaglia F,Rapaccini GL,Di Marco M,Caturelli E,Zoli M,Borzio F,Cabibbo G,Felder M,Gasbarrini A,Sacco R,Foschi FG,Missale G,Morisco F,Svegliati Baroni G,Virdone R.Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages:a multicentre study. Journal of Hepatology . 2015 被引量:1
  • 5Roayaie S,Jibara G,Tabrizian P,Park JW,Yang J,Yan L,Schwartz M,Han G,Izzo F,Chen M,Blanc JF,Johnson P,Kudo M,Roberts LR,Sherman M.The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology . 2015 被引量:1
  • 6Torzilli G,Belghiti J,Kokudo N,Takayama T,Capussotti L,Nuzzo G,Vauthey JN,Choti MA,De Santibanes E,Donadon M,Morenghi E,Makuuchi M.A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers:is it adherent to the EASL/AASLD recommendations?:an observational study of the HCC East-West study group. Annals of Surgery . 2013 被引量:2
  • 7El-Serag HB.Hepatocellular carcinoma. The New England Journal of Medicine . 2011 被引量:7
  • 8Akaike H.A new look at the statistical model identification. IEEE Transactions on Automatic Control . 1974 被引量:4
  • 9Llovet JM,Fuster J,Bruix J.Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology . 1999 被引量:3
  • 10Jordi Bruix,Morris Sherman,Josep M Llovet,Michel Beaugrand,Riccardo Lencioni,Andrew K Burroughs,Erik Christensen,Luigi Pagliaro,Massimo Colombo,Juan Rodés.Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference[J].Journal of Hepatology.2001(3) 被引量:11

共引文献115

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部